Advantest Corporation (NYSE:ATE) shares fell -2.47% in last trading session and ended the day at $8.67. ATE Gross Margin is 55.00% and its has a return on assets of 4.80%. Advantest Corporation (NYSE:ATE) quarterly performance is 3.46%.
W2BI, Inc., a member of the Advantest Group (NYSE:ATE), announced that it will again exhibit at the annual Mobile World Congress taking place in Barcelona, Spain, February 22-25. W2BI will demonstrate its new, lower cost portable cloud-managed test environment for wireless device testing, including Internet of Things (IoT) targeted test cases. Also featured at MWC will be W2BI’s SmartBox™ system-level production assembly test system, and its automated test suites that enable customers to produce smart devices and services with improved quality and time-to-market.
Baker Hughes Incorporated (NYSE:BHI) ended the last trading day at $39.78. Company weekly volatility is calculated as 3.92% and price to cash ratio as 7.46. Baker Hughes Incorporated (NYSE:BHI) showed a weekly performance of -10.08%.
Baker Hughes Incorporated (NYSE:BHI) Chairman and Chief Executive Officer Martin S. Craighead announced that the Baker Hughes Board of Directors declared the regular quarterly cash dividend of $0.17 per share of common stock payable March 23, 2016 to holders of record on March 2, 2016.
On 11 February, Wolverine World Wide Inc. (NYSE:WWW) shares fell -2.24% and was closed at $16.14. WWW EPS growth in last 5 year was 16.00%. Wolverine World Wide Inc. (NYSE:WWW) year to date (YTD) performance is -3.41%.
Wolverine World Wide, Inc. (NYSE:WWW) announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per share of common stock. The dividend is payable on May 2, 2016, to stockholders of record on April 1, 2016. The dividend is equal to the last quarterly dividend and reflects an indicated annual dividend of $0.24 per share.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) shares moved up 5.10% in last trading session and ended the day at $4.53. MRNS has a return on assets of -47.90%. Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) quarterly performance is -18.08%.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, announced it participated in the Canaccord Genuity 2016 Rare Disease, BioPharma One-on-One Day, on Tuesday, February 2, 2016 at the Omni Berkshire Place in New York.
SunEdison, Inc. (NYSE:SUNE) caters to the Technology space. It has a net profit margin of -62.50% and weekly performance is -28.67%. On the last day of trading company shares ended up at $2.04. SunEdison, Inc. (NYSE:SUNE) distance from 50-day simple moving average (SMA50) is -47.55%.
Levi & Korsinsky LLP is investigating possible illegal conduct related to SunEdison’s (NYSE:SUNE) Retirement Savings Plan. The investigation concerns possible violations of the Employee Retirement Income Security Act of 1974 (“ERISA”).